Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Fundamental data now powered by FactSet with hourly updates!

TLIS | Talis Biomedical Corp

Healthcare | Medical Devices | USA | NASD

Index	-	P/E	-	EPS (ttm)	-10.92	Insider Own	56.22%	Shs Outstand	1.79M	Perf Week	1.05%
Market Cap	21.95M	Forward P/E	-	EPS next Y	-23.32	Insider Trans	0.00%	Shs Float	1.67M	Perf Month	-8.57%
Income	-85.81M	PEG	-	EPS next Q	-7.37	Inst Own	19.22%	Short Float / Ratio	0.84% / 1.08	Perf Quarter	-14.48%
Sales	1.02M	P/S	21.52	EPS this Y	49.35%	Inst Trans	-72.27%	Short Interest	0.01M	Perf Half Y	-21.26%
Book/sh	25.24	P/B	0.23	EPS next Y	27.60%	ROA	-49.78%	Target Price	5.25	Perf Year	-47.40%
Cash/sh	26.04	P/C	0.22	EPS next 5Y	-	ROE	-62.83%	52W Range	5.40 - 13.50	Perf YTD	-13.84%
Dividend	-	P/FCF	-	EPS past 5Y	-80.47%	ROI	-75.40%	52W High	-57.33%	Beta	1.12
Dividend %	-	Quick Ratio	11.01	Sales past 5Y	35.36%	Gross Margin	-1528.86%	52W Low	6.67%	ATR	0.42
Employees	102	Current Ratio	11.01	Sales Q/Q	-90.44%	Oper. Margin	-8661.84%	RSI (14)	41.83	Volatility	7.72% 6.34%
Optionable	No	Debt/Eq	0.21	EPS Q/Q	-715.30%	Profit Margin	-8396.77%	Rel Volume	0.15	Prev Close	5.52
Shortable	Yes	LT Debt/Eq	0.18	Earnings	Aug 10 AMC	Payout	-	Avg Volume	12.98K	Price	5.76
Recom	5.00	SMA20	-5.08%	SMA50	-15.35%	SMA200	-23.79%	Volume	1,028	Change	4.35%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-07-22	Downgrade	BofA Securities	Neutral → Underperform	$3
Sep-27-21	Downgrade	JP Morgan	Neutral → Underweight	$10 → $7
Aug-31-21	Downgrade	BTIG Research	Buy → Neutral
Aug-12-21	Downgrade	Piper Sandler	Overweight → Neutral	$13 → $9
Aug-11-21	Downgrade	JP Morgan	Overweight → Neutral	$17 → $10
Mar-09-21	Initiated	Piper Sandler	Overweight	$17
Mar-09-21	Initiated	JP Morgan	Overweight	$18
Mar-09-21	Initiated	BTIG Research	Buy	$18
Mar-09-21	Initiated	BofA Securities	Neutral	$14

Aug-10-23 04:45PM	Talis: Q2 Earnings Snapshot (AP Finance)
04:05PM	Talis Biomedical Announces Second Quarter 2023 Financial Results and Business Update (GlobeNewswire)
Aug-03-23 08:00AM	Talis Biomedical to Report Second Quarter 2023 Financial Results and Provide a Business Update on August 10, 2023 (GlobeNewswire)
Aug-02-23 08:00AM	Talis Biomedical Announces Andrew Lukowiak, Ph.D., as President and Chief Scientific Officer (CSO) (GlobeNewswire)
Jul-27-23 08:00AM	New Data Presented at the Infectious Disease Society for Obstetrics and Gynecology (IDSOG) Annual Meeting Differentiate Talis Biomedicals Womens and Sexual Health Product Menu (GlobeNewswire)
08:00AM	Loading…
Jul-24-23 08:00AM	Talis Biomedical Regains Compliance with Nasdaq Minimum Bid Price Requirement (GlobeNewswire) +7.26%
Jul-05-23 08:00AM	Talis Biomedical Announces 1-for-15 Reverse Stock Split (GlobeNewswire)
May-23-23 08:00AM	Talis Biomedical Appoints Former Roche Molecular CEO Heiner Dreismann to Board of Directors, Announces Former Genomic Health CEO Kim Popovits as Lead Independent Director (GlobeNewswire)
May-11-23 05:22PM	Talis: Q1 Earnings Snapshot (AP Finance)
04:05PM	Talis Biomedical Announces Business Update and First Quarter 2023 Financial Results (GlobeNewswire)
May-04-23 08:00AM	Talis Biomedical to Provide Business Update and Financial Results on May 11, 2023 (GlobeNewswire)
Mar-22-23 04:05PM	Talis Announces Fourth Quarter and Full Year 2022 Financial Results (GlobeNewswire)
Nov-09-22 06:13AM	Talis Biomedical Third Quarter 2022 Earnings: Revenues Beat Expectations, EPS Lags (Simply Wall St.)
Nov-03-22 04:05PM	Talis Biomedical Reports Third Quarter 2022 Financial Results (GlobeNewswire)
Aug-08-22 10:48AM	Winner of Trump-era Covid test competition to cut 57 jobs, shift into women's and sexual health tests (American City Business Journals)
07:50AM	Loading…
Aug-03-22 07:50AM	Talis Biomedical Stops Work On COVID-19 Assay, Cuts Workforce (Benzinga)
Aug-02-22 04:05PM	Talis Biomedical Provides Business Update and Reports Second Quarter Financial Results (GlobeNewswire)
May-10-22 04:05PM	Talis Biomedical Announces First Quarter 2022 Financial Results (GlobeNewswire) +13.46%
11:08AM	Can Talis Biomedical (NASDAQ:TLIS) Afford To Invest In Growth? (Simply Wall St.)
Apr-26-22 08:00AM	Talis Biomedical to Announce First Quarter 2022 Financial Results on May 10, 2022 (GlobeNewswire)
Apr-25-22 12:08PM	Talis Biomedical stock bounces off record low after largest shareholder pulls share-sale plans (MarketWatch) +5.61%
Apr-06-22 06:11PM	Top 10 Stocks Billionaire David Einhorn Just Added to His Portfolio (Insider Monkey)
Mar-15-22 09:30PM	Talis Biomedical Corporation (TLIS) Q4 2021 Earnings Call Transcript (Motley Fool)
04:05PM	Talis Biomedical Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financial Results (GlobeNewswire)
Mar-01-22 08:00AM	Talis Biomedical to Announce Fourth Quarter and Full Year Financial Results on March 15, 2022 (GlobeNewswire) -6.70%
Feb-23-22 04:23AM	Talis Biomedical (NASDAQ:TLIS) shareholders have endured a 89% loss from investing in the stock a year ago (Simply Wall St.)
Feb-01-22 10:05AM	Deadline in Lawsuit for Investors with Losses over $150,000 in Talis Biomedical Corporation (NASDAQ: TLIS) shares announced by Shareholders Foundation (ACCESSWIRE)
Dec-25-21 02:38AM	Federated Hermes Prudent Bear Fund Buys PowerShares QQQ Trust Ser 1, iShares Russell 2000 ETF, ... (GuruFocus.com)
Dec-21-21 02:00PM	Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Its Investigation of Talis Biomedical Corporation (TLIS) on Behalf of Investors (GlobeNewswire)
Dec-20-21 04:00PM	INVESTOR ALERT: Law Offices of Howard G. Smith Continues Its Investigation of Talis Biomedical Corporation (TLIS) on Behalf of Investors (GlobeNewswire)
11:16AM	Loading…
Dec-14-21 11:16AM	Insiders may be rethinking their US$6.4m Talis Biomedical Corporation (NASDAQ:TLIS) investment now that the company has lost US$27m in value (Simply Wall St.)
Dec-13-21 11:30PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Talis Biomedical Corporation - TLIS (PR Newswire)
12:15PM	Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders Talis Biomedical Corporation (TLIS) Investigation (ACCESSWIRE)
10:00AM	Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Its Investigation of Talis Biomedical Corporation (TLIS) on Behalf of Investors (GlobeNewswire)
Dec-10-21 09:00AM	INVESTOR ALERT: Law Offices of Howard G. Smith Continues Its Investigation of Talis Biomedical Corporation (TLIS) on Behalf of Investors (GlobeNewswire)
Dec-09-21 06:16PM	INVESTOR ALERT: Kirby McInerney LLP Announces an Investigation of Shareholder Claims on Behalf of Talis Biomedical Corporation (TLIS) Investors (GlobeNewswire)
Dec-08-21 07:30PM	INVESTOR ALERT: Law Offices of Howard G. Smith Continues Its Investigation of Talis Biomedical Corporation (TLIS) on Behalf of Investors (Business Wire) -11.39%
06:21PM	The Law Offices of Frank R. Cruz Continues Its Investigation of Talis Biomedical Corporation (TLIS) on Behalf of Investors (Business Wire)
03:51PM	Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Its Investigation of Talis Biomedical Corporation (TLIS) on Behalf of Investors (Business Wire)
08:00AM	Talis Biomedical Announces Leadership Transition (GlobeNewswire)
Dec-03-21 03:15PM	The Law Offices of Frank R. Cruz Continues Investigation of Talis Biomedical Corporation (TLIS) on Behalf of Investors (PR Newswire)
10:00AM	INVESTOR ALERT: Law Offices of Howard G. Smith Continues Its Investigation of Talis Biomedical Corporation (TLIS) on Behalf of Investors (PR Newswire)
Dec-02-21 06:53PM	Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Its Investigation of Talis Biomedical Corporation (TLIS) on Behalf of Investors (PR Newswire)
05:00PM	Talis Biomedical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Nov-16-21 06:00AM	Talis Biomedical Corporation (TLIS) Q3 2021 Earnings Call Transcript (Motley Fool) -17.93%
Nov-15-21 04:05PM	Talis Biomedical Announces Third Quarter 2021 Financial Results and Business Progress (GlobeNewswire)
04:02PM	Talis Biomedical Announces Appointment of Brian Blaser as President, Chief Executive Officer and Director (GlobeNewswire)
Nov-12-21 12:00PM	Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Its Investigation of Talis Biomedical Corporation (TLIS) on Behalf of Investors (GlobeNewswire) +5.01%
Nov-11-21 04:00PM	INVESTOR ALERT: Law Offices of Howard G. Smith Continues Its Investigation of Talis Biomedical Corporation (TLIS) on Behalf of Investors (GlobeNewswire)
Nov-08-21 08:00AM	Talis Biomedical Granted FDA Emergency Use Authorization (EUA) for COVID-19 Molecular Point-of-Care Test to Detect SARS-CoV-2 (GlobeNewswire) +16.86%
Oct-26-21 08:00AM	Talis Biomedical to Announce Third Quarter 2021 Financial Results on November 15, 2021 (GlobeNewswire)
Oct-12-21 12:36PM	What Type Of Shareholders Make Up Talis Biomedical Corporation's (NASDAQ:TLIS) Share Registry? (Simply Wall St.)
Sep-14-21 04:00PM	Glancy Prongay & Murray LLP, a National Class Action Law Firm, Continues Investigation of Talis Biomedical Corporation (TLIS) on Behalf of Investors (Business Wire)
01:32PM	INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of Talis Biomedical Corporation (TLIS) on Behalf of Investors (Business Wire)
Sep-13-21 07:00PM	TALIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Talis on Behalf of Talis Stockholders and Encourages Investors to Contact the Firm (Business Wire)
Sep-09-21 06:00PM	Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Talis Biomedical Corporation (TLIS) on Behalf of Investors (Business Wire)
03:15PM	The Law Offices of Frank R. Cruz Continues Investigation of Talis Biomedical Corporation (TLIS) on Behalf of Investors (Business Wire)
Sep-03-21 08:49AM	TLIS Alert: Johnson Fistel Launches Investigation into Talis Biomedical - Stock Price has Plummeted since IPO; Investors Suffering Losses Encouraged to Contact the Firm (GlobeNewswire)
Aug-31-21 08:25PM	The Law Offices of Frank R. Cruz Announces Investigation of Talis Biomedical Corporation (TLIS) on Behalf of Investors (Business Wire) -11.04%
Aug-30-21 04:30PM	Talis Biomedical Announces CEO Transition (GlobeNewswire) +6.21%
Aug-11-21 02:10PM	Talis Biomedical (TLIS) Q2 2021 Earnings Call Transcript (Motley Fool) -6.47%
Aug-10-21 04:05PM	Talis Biomedical Announces Second Quarter 2021 Financial Results and Business Progress (GlobeNewswire) -7.24%
08:25AM	We're Keeping An Eye On Talis Biomedical's (NASDAQ:TLIS) Cash Burn Rate (Simply Wall St.)
Jul-27-21 08:00AM	Talis Biomedical to Announce Second Quarter 2021 Financial Results on August 10, 2021 (GlobeNewswire)
May-12-21 08:00AM	Have Insiders Been Buying Talis Biomedical Corporation (NASDAQ:TLIS) Shares? (Simply Wall St.) +8.78%
May-11-21 04:05PM	Talis Biomedical Announces First Quarter 2021 Financial Results and Business Progress (GlobeNewswire)
02:30PM	Talis Biomedical Corp to Host Earnings Call (ACCESSWIRE)
May-04-21 08:00AM	Talis Biomedical to Announce First Quarter 2021 Financial Results on May 11, 2021 (GlobeNewswire)
Apr-28-21 08:00AM	Talis Biomedical to Participate in Upcoming BofA Securities 2021 Virtual Healthcare Conference (GlobeNewswire)
Mar-18-21 08:00AM	Talis Appoints Jeryl Hilleman to Board of Directors (GlobeNewswire)
Mar-09-21 10:07AM	Benzinga's Top Ratings Upgrades, Downgrades For March 9, 2021 (Benzinga)
Mar-08-21 08:00AM	Talis Provides Update on Regulatory Pathway for Emergency Use Authorization (EUA) of its Talis One COVID-19 Test (GlobeNewswire) -12.29%
Feb-17-21 04:05PM	Talis Announces Closing of Initial Public Offering and Full Exercise of Underwriters Option to Purchase Additional Shares (GlobeNewswire)
Feb-12-21 05:05PM	Talis Biomedical, Decibel and NexImmune make their market debuts (Barrons.com)
Feb-11-21 11:39PM	Talis Announces Pricing of Initial Public Offering (GlobeNewswire)

Talis Biomedical Corp. develops and commercializes innovative products that are designed to enable accurate, reliable, low cost and rapid molecular testing for infectious diseases. The company was founded on June 26, 2013 and is headquartered in Redwood City, CA.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

TLIS | Talis Biomedical Corp

Upgrade your FINVIZ experience